Cefsulodin is an antibiotic that belongs to a group of medications known as cephalosporins. It is used to treat a wide variety of bacterial infections, including those of the respiratory tract, skin, soft tissue, ear, and urinary tract. It works by stopping the growth of bacteria. Cefsulodin may also be used in combination with other antibiotics to treat certain infections. Common side effects of cefsulodin include upset stomach, nausea, and diarrhea.
Cefsulodin is a third-generation cephalosporin antibiotic that was discovered in 1977. It is primarily active against Pseudomonas aeruginosa, a bacterium that can cause a variety of infections, including pneumonia, urinary tract infections, and skin infections.
Cefsulodin is not typically used as a first-line treatment for any of these infections because it has a narrow spectrum of activity, meaning it is only effective against a limited number of bacteria. Additionally, it is not available in the United States and is only available in a limited number of other countries.
However, cefsulodin may be an option for treating infections caused by P. aeruginosa that are resistant to other antibiotics. It is also sometimes used in research settings to study the effects of P. aeruginosa on human cells.